NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000494

Registered date:29/09/2006

Clinical study of influenza vaccine in infants; dose and immunogenicity

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedinfluenza
Date of first enrollment2006/10/01
Target sample size200
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Influenza HA vaccine is inoculated twice at 4 weeks interval. Side reaction survey and antibody titer measurement are conducted after inoculations.

Outcome(s)

Primary OutcomeHI titers before and after vaccination. Survey on side reaction after vaccination.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum6months-old
Age maximum48months-old
GenderMale and Female
Include criteria
Exclude criteria1.Infants with a fever at the time of planned vaccination. 2.Infants with serious acute diseases. 3.Infants who has induced anaphylaxis by the substances of the vaccine. 4.Infants considered inappropriate to be inoculated vaccine.

Related Information

Contact

public contact
Name
Address 2-13-16 Jigyo Chuo-ku, Fukuoka Japan
Telephone
E-mail
Affiliation Medical Co. LTA Kyushu Clinical Pharmacology Research Clinic Clinical Pharmacology Department
scientific contact
Name Shin Irie
Address 2-13-16 Jigyo Chuo-ku, Fukuoka Japan
Telephone
E-mail
Affiliation Medical Co. LTA Kyushu Clinical Pharmacology Research Clinic Clinical Pharmacology Department